261 related articles for article (PubMed ID: 26200625)
1. Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.
Fernández-Nebro A; Rúa-Figueroa Í; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Ordóñez-Cañizares C; Martín-Martínez MA; Blanco R; Melero-González R; Ibáñez-Rúan J; Bernal-Vidal JA; Tomero-Muriel E; Uriarte-Isacelaya E; Horcada-Rubio L; Freire-González M; Narváez J; Boteanu AL; Santos-Soler G; Andreu JL; Pego-Reigosa JM
Medicine (Baltimore); 2015 Jul; 94(29):e1183. PubMed ID: 26200625
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I; Fernández Castro M; Andreu JL; Sanchez-Piedra C; Martínez-Taboada V; Olivé A; López-Longo J; Rosas J; Galindo M; Calvo-Alén J; Fernández-Nebro A; Alonso F; Rodríguez-Lozano B; Alberto García Vadillo J; Menor R; Narváez FJ; Erausquin C; García-Aparicio Á; Tomero E; Manrique-Arija S; Horcada L; Uriarte E; Gil S; Blanco R; López-González R; Boteanu A; Freire M; Galisteo C; Rodríguez-Gómez M; Díez-Álvarez E; Pego-Reigosa JM;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):38-45. PubMed ID: 27564390
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
[TBL] [Abstract][Full Text] [Related]
4. Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus.
Kao AH; Lertratanakul A; Elliott JR; Sattar A; Santelices L; Shaw P; Birru M; Avram Z; Thompson T; Sutton-Tyrrell K; Ramsey-Goldman R; Manzi S
Am J Cardiol; 2013 Oct; 112(7):1025-32. PubMed ID: 23827400
[TBL] [Abstract][Full Text] [Related]
5. Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network.
Fernández-Garcés M; Haro G; Micó ML
Medicine (Baltimore); 2019 Oct; 98(43):e17489. PubMed ID: 31651851
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.
Rúa-Figueroa Í; Richi P; López-Longo FJ; Galindo M; Calvo-Alén J; Olivé-Marqués A; Loza-Santamaría E; Vicente SP; Erausquin C; Tomero E; Horcada L; Uriarte E; Sánchez-Atrio A; Rosas J; Montilla C; Fernández-Nebro A; Rodríguez-Gómez M; Vela P; Blanco R; Freire M; Silva L; Díez-Álvarez E; Ibáñez-Barceló M; Zea A; Narváez J; Martínez-Taboada V; Marenco JL; de Castro MF; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas JJ; Pecondón Á; Marras C; Carreira P; Bonilla G; Torrente V; Castellví I; Alegre J; Moreno M; Raya E; de la Peña PG; Vázquez T; Aguirre Á; Quevedo V; Pego-Reigosa JM;
Medicine (Baltimore); 2015 Jan; 94(1):e267. PubMed ID: 25569641
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.
Toloza SM; Uribe AG; McGwin G; Alarcón GS; Fessler BJ; Bastian HM; Vilá LM; Wu R; Shoenfeld Y; Roseman JM; Reveille JD;
Arthritis Rheum; 2004 Dec; 50(12):3947-57. PubMed ID: 15593203
[TBL] [Abstract][Full Text] [Related]
8. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.
Narváez J; Borrell H; Sánchez-Alonso F; Rúa-Figueroa I; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Fernández-Nebro A; Olivé A; Andreu JL; Martínez-Taboada V; Nolla JM; Pego-Reigosa JM;
Arthritis Res Ther; 2018 Dec; 20(1):280. PubMed ID: 30567600
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
11. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).
Hernández Cruz B; Alonso F; Calvo Alén J; Pego-Reigosa JM; López-Longo FJ; Galindo-Izquierdo M; Olivé A; Tomero E; Horcada L; Uriarte E; Erausquin C; Sánchez-Atrio A; Montilla C; Santos Soler G; Fernández-Nebro A; Blanco R; Rodríguez-Gómez M; Vela P; Freire M; Díez-Álvarez E; Boteanu AL; Narváez J; Martínez Taboada V; Ruiz-Lucea E; Andreu JL; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Pérez-Venegas JJ; Ibáñez-Barceló M; Pecondón-Español Á; Marras C; Bonilla G; Castellví I; Moreno M; Raya E; Quevedo Vila VE; Vázquez T; Ruán JI; Muñoz S; Rúa-Figueroa Í;
Lupus; 2020 Jan; 29(1):27-36. PubMed ID: 31801040
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
Frerix M; Stegbauer J; Kreuter A; Weiner SM
Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
[TBL] [Abstract][Full Text] [Related]
13. [Atherosclerosis in systemic lupus erythematosus].
Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
[TBL] [Abstract][Full Text] [Related]
14. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
Ajeganova S; Hafström I; Frostegård J
Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
[TBL] [Abstract][Full Text] [Related]
15. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER).
Riveros Frutos A; Holgado S; Sanvisens Bergé A; Casas I; Olivé A; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Rúa-Figueroa I;
Rheumatology (Oxford); 2021 Apr; 60(4):1793-1803. PubMed ID: 33106841
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
17. Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors.
Erdozain JG; Villar I; Nieto J; Ruiz-Irastorza G
J Rheumatol; 2014 Feb; 41(2):310-7. PubMed ID: 24429176
[TBL] [Abstract][Full Text] [Related]
18. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.
Urowitz MB; Gladman D; Ibañez D; Bae SC; Sanchez-Guerrero J; Gordon C; Clarke A; Bernatsky S; Fortin PR; Hanly JG; Wallace DJ; Isenberg D; Rahman A; Alarcón GS; Merrill JT; Ginzler E; Khamashta M; Nived O; Sturfelt G; Bruce IN; Steinsson K; Manzi S; Ramsey-Goldman R; Dooley MA; Zoma A; Kalunian K; Ramos M; Van Vollenhoven RF; Aranow C; Stoll T; Petri M; Maddison P;
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):881-7. PubMed ID: 20535799
[TBL] [Abstract][Full Text] [Related]
20. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology.
Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo-Izquierdo M; Loza E; García de Yebenes MJ; Pego-Reigosa JM; ;
Reumatol Clin; 2014; 10(1):17-24. PubMed ID: 23871155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
